Live Quote · OTCIPSEFHealthcare · Medical - Pharmaceuticals

Ipsen S.A.

$113.13▲ 0.00%(+$0.00)

TickerSpark Score

70/100

▌ Solid

80

Valuation

80

Profitability

65

Growth

96

Health

30

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IPSEF research report →

52-Week Range0% of range

Low

$113.13

Current

$113.13

High

$185.93

Company Overviewwww.ipsen.com

About the company

Ipsen S. A. , a biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience worldwide.

CEO: David G. Loew
IPO: 2009
Employees: 5,535
HQ: Paris, BC, FR

Price Chart

+0.00% · this period

Valuation

Market Cap: $9.35B
P/E: 31.79
P/S: 3.84
P/B: 3.24
EV/EBITDA: 12.20
Div Yield: 0.94%

Profitability

Gross Margin: 70.58%
Op Margin: 30.70%
Net Margin: 12.07%
ROE: 10.36%
ROIC: 15.68%

Growth & Income

Revenue: $3.67B · 2.80%
Net Income: $444.33M · 28.46%
EPS: $5.32 · 23.15%
Op Income: $746.02M
FCF YoY: 676.48%

Performance & Tape

52W High: $185.93
52W Low: $113.13
50D MA: $113.13
200D MA: $113.13
Beta: 0.32
Avg Volume: 9.86

Get TickerSpark's AI analysis on IPSEF

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · IPSEF